共 246 条
[1]
Hendriks YM(2006)Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome) Gastroenterology 130 312-322
[2]
Jagmohan-Changur S(2013)Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Gut 62 812-823
[3]
van der Klift HM(1996)Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues Cancer Res 56 235-240
[4]
Morreau H(1996)Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes Cancer Res 56 4836-4840
[5]
van Puijenbroek M(2008)Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry J Mol Diagn 10 293-300
[6]
Tops C(2008)Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing J Mol Diagn 10 301-307
[7]
van Os T(2013)Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer Gut 62 272-279
[8]
Wagner A(2009)EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome Genet Med 11 42-65
[9]
Ausems MG(2012)Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline J Genet Couns 21 484-493
[10]
Gomez E(2005)Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer Gastroenterology 128 1160-1171